BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38703163)

  • 1. Lipomatous Metaplasia Is Associated With Ventricular Tachycardia Recurrence Following Ablation in Patients With Nonischemic Cardiomyopathy.
    Xu L; Khoshknab M; Moss J; Berger RD; Chrispin J; Callans D; Marchlinski FE; Zimmerman SL; Han Y; Trayanova N; Desjardins B; Nazarian S
    JACC Clin Electrophysiol; 2024 Jun; 10(6):1135-1146. PubMed ID: 38703163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study.
    Vaseghi M; Hu TY; Tung R; Vergara P; Frankel DS; Di Biase L; Tedrow UB; Gornbein JA; Yu R; Mathuria N; Nakahara S; Tzou WS; Sauer WH; Burkhardt JD; Tholakanahalli VN; Dickfeld TM; Weiss JP; Bunch TJ; Reddy M; Callans DJ; Lakkireddy DR; Natale A; Marchlinski FE; Stevenson WG; Della Bella P; Shivkumar K
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1141-1150. PubMed ID: 30236386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cardiac magnetic resonance septal late gadolinium enhancement patterns for periaortic ventricular tachycardia ablation: Heterogeneity of the anteroseptal substrate in nonischemic cardiomyopathy.
    Nishimura T; Patel HN; Wang S; Upadhyay GA; Smith HL; Ozcan C; Shatz DY; Nayak HM; Patel AR; Tung R
    Heart Rhythm; 2021 Apr; 18(4):579-588. PubMed ID: 33301979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of septal late gadolinium enhancement on cardiac magnetic resonance with ventricular tachycardia ablation targets in nonischemic cardiomyopathy.
    Kuo L; Liang JJ; Han Y; Frankel DS; Santangeli P; Callans DJ; Zado ES; Marchlinski FE; Desjardins B; Nazarian S
    J Cardiovasc Electrophysiol; 2020 Dec; 31(12):3262-3276. PubMed ID: 33070414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Substrate Characterization by CMR T
    Muser D; Nucifora G; Castro SA; Enriquez A; Chahal CAA; Magnani S; Kumareswaran R; Arkles J; Supple G; Schaller R; Hyman M; Dixit S; Lin D; Zado ES; Tschabrunn C; Callans DJ; Nazarian S; Frankel DS; Marchlinski FE; Santangeli P
    JACC Clin Electrophysiol; 2021 Jul; 7(7):831-840. PubMed ID: 33516709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac magnetic resonance to predict recurrences after ventricular tachycardia ablation: septal involvement, transmural channels, and left ventricular mass.
    Quinto L; Sanchez P; Alarcón F; Garre P; Zaraket F; Prat-Gonzalez S; Ortiz-Perez JT; JesúsPerea R; Guasch E; Tolosana JM; San Antonio R; Arbelo E; Sitges M; Brugada J; Berruezo A; Mont L; Roca-Luque I
    Europace; 2021 Sep; 23(9):1437-1445. PubMed ID: 34142121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.
    Okubo K; Gigli L; Trevisi N; Foppoli L; Radinovic A; Bisceglia C; Frontera A; D'Angelo G; Cireddu M; Paglino G; Mazzone P; Della Bella P
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008307. PubMed ID: 32657137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging and histopathology of catheter ablation lesions after ventricular tachycardia ablation in patients with nonischemic cardiomyopathy.
    Ghannam M; Liang JJ; Attili A; Cochet H; Jais P; Latchamsetty R; Jongnarangsin K; Morady F; Gordon D; Bogun F
    Heart Rhythm; 2022 Oct; 19(10):1642-1649. PubMed ID: 35772697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia.
    Yamashita S; Sacher F; Mahida S; Berte B; Lim HS; Komatsu Y; Amraoui S; Denis A; Derval N; Laurent F; Sermesant M; Montaudon M; Hocini M; Haïssaguerre M; Jaïs P; Cochet H
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):699-708. PubMed ID: 26918883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach?
    Reithmann C; Herkommer B; Fiek M
    Clin Res Cardiol; 2016 Oct; 105(10):827-37. PubMed ID: 27294860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate Characterization and Outcome of Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy and Isolated Epicardial Scar.
    Liuba I; Muser D; Chahal A; Tschabrunn C; Santangeli P; Kuo L; Frankel DS; Callans DJ; Garcia F; Supple GE; Schaller RD; Dixit S; Lin D; Nazarian S; Kumareswaran R; Arkles J; Riley MP; Hyman MC; Walsh K; Guandalini G; Arceluz M; Pothineni NVK; Zado ES; Marchlinski F
    Circ Arrhythm Electrophysiol; 2021 Dec; 14(12):e010279. PubMed ID: 34847692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy with near-normal left ventricular ejection fraction.
    Bennett RG; Campbell T; Kotake Y; Turnbull S; Kumar S
    Heart Rhythm; 2022 Jan; 19(1):51-60. PubMed ID: 34597769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinus rhythm QRS amplitude and fractionation in patients with nonischemic cardiomyopathy to identify ventricular tachycardia substrate and location.
    Arceluz MR; Liuba I; Tschabrunn CM; Frankel DS; Santangeli P; Supple GE; Schaller RD; Garcia FC; Callans DJ; Guandalini GS; Walsh K; Nazarian S; Zado ES; Marchlinski FE
    Heart Rhythm; 2022 Feb; 19(2):187-194. PubMed ID: 34601127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VT Recurrence After Ablation: Incomplete Ablation or Disease Progression? A Multicentric European Study.
    Berte B; Sacher F; Venlet J; Andreu D; Mahida S; Aldhoon B; DE Potter T; Sarkozy A; Tavernier R; Andronache M; Deneke T; Kautzner J; Berruezo A; Cochet H; Zeppenfeld K; Jaïs P
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):80-7. PubMed ID: 26471955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.
    Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG
    Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of preprocedural cardiac magnetic resonance imaging with outcomes of ventricular tachycardia ablation in patients with idiopathic dilated cardiomyopathy.
    Siontis KC; Kim HM; Sharaf Dabbagh G; Latchamsetty R; Stojanovska J; Jongnarangsin K; Morady F; Bogun FM
    Heart Rhythm; 2017 Oct; 14(10):1487-1493. PubMed ID: 28603002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of simultaneous unipolar radiofrequency catheter ablation for intramural septal ventricular tachycardia in nonischemic cardiomyopathy.
    Yang J; Liang J; Shirai Y; Muser D; Garcia FC; Callans DJ; Marchlinski FE; Santangeli P
    Heart Rhythm; 2019 Jun; 16(6):863-870. PubMed ID: 30576879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
    Siontis KC; Santangeli P; Muser D; Marchlinski FE; Zeppenfeld K; Hoogendoorn JC; Narasimhan C; Sauer WH; Zipse MM; Kapa S; Vedantham V; Rosenthal DG; Robinson MR; Patton KK; Murgatroyd F; Chicos AB; Soejima K; Roukoz H; Sacher F; Bhan A; Appelbaum J; Dickfeld T; Mankad P; Ellenbogen KA; Kron J; Kim HM; Froehlich J; Eagle KA; Bogun FM; Crawford TC
    JAMA Cardiol; 2022 Feb; 7(2):175-183. PubMed ID: 34787643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipomatous Metaplasia Facilitates Slow Conduction in Critical Ventricular Tachycardia Corridors Within Postinfarct Myocardium.
    Xu L; Zahid S; Khoshknab M; Moss J; Berger RD; Chrispin J; Callans D; Marchlinski FE; Zimmerman SL; Han Y; Desjardins B; Trayanova N; Nazarian S
    JACC Clin Electrophysiol; 2023 Aug; 9(8 Pt 1):1235-1245. PubMed ID: 37227343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.